Company Overview - Precision Optics (POCI) is a vertically integrated optics company focused on micro-optics and imaging technologies for the healthcare and defense/aerospace industries[7] - The company's business model involves close collaboration with medical device and defense companies from the early design stages through manufacturing[13, 14] - The company has launched Unity CMOS Imaging Platform to drive growth in development pipeline[11] Financial Performance - The company's revenue has grown from $3.9 million in 2016 to $19.1 million in 2024[51] - The company's gross margin was 30.3% in 2024[54] - The company's adjusted EBITDA was -$1.55 million in 2024[57] Recent Orders and Backlog - The company announced a $9 million production order in May 2024 for a single-use cystoscopy program[47] - The company has minimum purchase commitments of nearly $4 million per year through calendar year 2026 for a top tier aerospace program[47] - The company's current customer program backlog is $6.6 million, expected to be delivered over the next 12 months (as of April 2025)[47] Growth Strategy - The company aims to continue and expand production lines for record backlog, especially for two recent large programs[48] - The company intends to advance pipeline projects to commercialization and expand the pipeline with new development programs leveraging the Unity Platform[48]

Ever use a Nintendo Switch to check your teeth before a date. Or find your kids lost toys under the couch. Today I'm toying with a springy snake light camera that can do those things.A USB endoscope. This one's an utterly cheap $10 model I bought off Amazon. One that just so happens to work with the Nintendo Switch 2's webcam feature or your Android phone.Its sensor and light just aren't strong enough to say see my dishwasher at work. But it's good enough to inspect my walls, check the connectors behind my ...

Company signs lease to move corporate offices and engineering development to Littleton, MA Move allows for expansion of production capabilities in Gardner, MA to meet increased backlog GARDNER, Mass. and LITTLETON, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced it has made the strategic decision to move its corporat ...

Summary of Precision Optics Corporation (POCI) Conference Call Company Overview - **Company Name**: Precision Optics Corporation (POCI) - **Ticker Symbol**: POCI, traded on NASDAQ - **Industry**: Optical systems design and manufacturing, focusing on medical devices and defense aerospace applications [2][3] Core Business Model - **Business Model**: Develops technology in optical systems, collaborates with customers to design products, and handles manufacturing [4][5] - **Revenue Growth**: Recent transition from product development to manufacturing is expected to significantly impact revenue positively [6][8] Financial Performance - **Revenue Trends**: Revenue has shown continuous growth over the past seven to eight years, with a slight pullback from fiscal 2023 to 2024 due to legacy products going end of life [7][30] - **Fiscal Year**: Fiscal year runs from July 1 to June 30, with expectations of revenue growth resuming towards the end of fiscal 2025 and into 2026 [8][30] - **Gross Margins**: Historically between 30% to 40%, currently lower due to startup challenges with new programs, with a target to return to 40% [31] - **Adjusted EBITDA**: Expected to reach $6 million in the current quarter, indicating a revenue run rate of $24 million, which would surpass breakeven [32][47] Key Technologies and Markets - **Micro Optics**: Focus on small optics for medical devices, particularly endoscopic systems [8][9] - **3D Imaging**: Development of high-precision imaging systems, including UHD and 3D endoscopes [10][14] - **Digital Imaging**: Integration of CMOS sensor technology into medical devices, enabling single-use endoscopes that enhance safety and reduce sterilization concerns [15][16][17] - **Market Segments**: - **Medical Devices**: Major focus area, contributing significantly to revenue [12][17] - **Defense Aerospace**: Represents about 30% of revenue, with opportunities in smaller optics for military applications [18][19] Production and Operational Challenges - **Production Ramp-Up**: Transitioning to larger volume production has faced challenges, including initial yield issues, particularly with the single-use cystoscope production line [36][38] - **Current Status**: Production rates have doubled since resolving initial challenges, with expectations for continued increases [39][42] Future Outlook and Strategy - **Pipeline Development**: Targeting two to four new programs to move into production each year, with several programs expected to commercialize in the next twelve months [50][52] - **Expansion Plans**: Plans to expand production capabilities and update facilities to support growth [28][29] - **Acquisition Strategy**: Continues to look for opportunistic acquisitions that align with technical synergies [30] Conclusion - **Positive Outlook**: The company is at an inflection point with strong customer demand and a focus on executing manufacturing processes, anticipating significant revenue growth in the near future [58][59]

M Update Japan Summit 2025: Bio CDMO to Drive Profit Growth in F3/27 We held a group meeting at Japan Summit 2025 (with Fujifilm HD CFO Masayuki Higuchi as main speaker). There was great interest from attendees in the healthcare segment (bio CDMO, medical systems). Management noted that although F3/25 results were mixed, it was overall on track to achieve goals in the current medium-term plan, with the OP jump from F3/26 (¥331bn as guidance) to F3/27, the final year (¥360bn), to be driven mainly by healthca ...

Precision Optics Corporation (POCI) Q3 2025 Earnings Call May 15, 2025 05:00 PM ET Speaker0 Welcome to the Precipio First Quarter twenty twenty five Shareholder Update Conference Call. All participants will be in listen only mode. Please note that the conference is being recorded. Statements made during this call contain forward looking statements about our business. You should not place undue reliance on forward looking statements as based upon our current expectations, forecasts and assumptions. Speaker1 ...

12 May 2025 | 4:49PM CST China Healthcare: Apr 2025 China hospital equipment bidding: Higher-than-expected MoM growth We continue to track the procurement value of main medical devices in China. As we had anticipated, YoY growth in April remained strong. What exceeded our expectations was that MoM growth also surpassed 10% (+13% vs GSe as 0 to +5%). This reflects a recovery in China hospital demand for medical equipment. Previously, United Imaging noted that current hospital procurement is still being suppo ...